STOCK TITAN

Allogene Therapeutics Stock Price, News & Analysis

ALLO Nasdaq

Welcome to our dedicated page for Allogene Therapeutics news (Ticker: ALLO), a resource for investors and traders seeking the latest updates and insights on Allogene Therapeutics stock.

Allogene Therapeutics, Inc. (ALLO) is a clinical-stage biotechnology leader developing off-the-shelf CAR T cell therapies for cancer and autoimmune diseases. This news hub provides investors and industry professionals with timely updates on clinical advancements, regulatory milestones, and strategic partnerships shaping the future of allogeneic cell treatments.

Access authoritative updates on ALLO's innovative pipeline, including progress with Dagger® technology and CRISPR-engineered therapies. Our curated news collection offers:

- Press releases detailing trial results and FDA interactions
- Financial reports and earnings call summaries
- Analysis of collaborations with academic and industry partners
- Updates on manufacturing scalability and therapeutic applications

Bookmark this page for centralized access to verified information on Allogene's progress in creating accessible, next-generation cell therapies. Check regularly for developments in hematologic malignancies, solid tumor treatments, and autoimmune disease research.

-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.23%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.85%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.95%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.09%
Tags
none

FAQ

What is the current stock price of Allogene Therapeutics (ALLO)?

The current stock price of Allogene Therapeutics (ALLO) is $1.18 as of May 8, 2025.

What is the market cap of Allogene Therapeutics (ALLO)?

The market cap of Allogene Therapeutics (ALLO) is approximately 369.6M.
Allogene Therapeutics

Nasdaq:ALLO

ALLO Rankings

ALLO Stock Data

369.61M
149.27M
17.73%
77.84%
18.65%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO